HPV Vaccination Best Practices Learning Collaborative

The AMGA Foundation is pleased to announce a call for participation for AMGA members to participate in an HPV Vaccination Best Practices Learning Collaborative.

Call for ParticipationAMGA and the National HPV Vaccination Roundtable are launching an 18-month learning collaborative to improve HPV vaccination rates among adolescents served by medical groups and integrated health systems.  This Collaborative is based off the successful work undertaken in AMGA’s Adult Immunization Best Practices Learning Collaborative which resulted in 5.5 million vaccinations administered or documented over a three year period. Funding was made possible by the Office of Infectious Disease and HIV/AIDS Policy (OIDP) via the Centers for Disease Control and Prevention under CFDA # 93.421 - Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation's Health, Cooperative Agreement grant number 6 NU38OT000283-02-01.

Eight health care organizations will be recruited to participate in the collaborative and to implement best practice interventions and strategies.

Who Should Apply

Organizations that want to be on the leading edge of adolescent population health management have the opportunity to team with other engaged organizations in a national forum. The objective of this program is to develop and implement evidence-based strategies and interventions to improve HPV vaccination rates in multi-specialty medical groups or integrated health systems with a focus on adolescents.  Collaborative members will be part of an elite group with unique access to national leaders and organizations at in-person events and during online webinars.

To learn more about the HPV Best Practices Learning Collaborative, download the Call for Participation for application guidelines. Applications are due no later than 5:30 p.m. PT on Thursday, October 31.

What We Already Know

Fourteen million Americans acquire HPV infections each year.  We do not know what infections will clear and which infections will not.  We do know that the HPV vaccine includes strains that cause over 90% of HPV cancers, mitigating patient risk. Approximately 92 people each day are diagnosed with an HPV-attributable cancer. These patients and their families face the emotional impact of a cancer diagnosis, the challenges of cancer treatment and the possibility of death. Health systems with missions to improve health, provide high quality care, and serve their communities have been caring for these patients as well as managing the high financial costs that accompany cancer care. Health systems are well positioned to expedite HPV vaccine uptake and help eliminate HPV cancers.

Collaborative Features

To help participants succeed, AMGA’s collaborative offers a wealth of resources and support, such as:

  • Two in-person meetings: February 2020 (kick-off) January 2021 (wrap-up)
  • Every other month webinars
  • Online resources -- a dedicated website for Collaborative participant material sharing and a listserv for idea sharing and collaboration
  • Consultation in the field from AMGA, National HPV Vaccination Roundtable, and external experts
  • Quality Improvement tools, resources, and outreach

Advisors

We have convened an advisory committee of industry and clinical experts that will provide guidance to the Collaborative on the development of objectives and educational content. The Committee includes:

Kara Elam, Ph.D., M.P.H., M.S.
ORISE Fellow in Vaccine Policy,
Office of Infectious Disease & HIV/AIDS Policy (OIDP),
U.S. Department of Health & Human Services

Melissa Gilkey, Ph.D.
Assistant Professor, Department of Health Behavior
University of North Carolina’s Gillings School of Global Health

Sarah Kobrin, Ph.D., M.P.H.
Chief of Health Systems & Research Branch
National Cancer Institute

Jason Maxwell, M.D.
Department Chair of Pediatrics and Practices
HealthPartners Como Clinic

Kristin Oliver, M.D., M.H.S.
Assistant Professor
Icahn School of Medicine at Mount Sinai, Department of Environmental Medicine and Public Health, Department of Pediatrics

Andrea Polkinghorn, B.S.N., RN-BC
Immunization Strategy Leader
Sanford Health

Melinda Wharton, M.D.
Director, Immunization Services Division, NCIRD
Centers for Disease Control and Prevention

Questions?

If you have questions or need further information, contact Erin Leaver-Schmidt at eleaver-schmidt@amga.org or by phone at 703.838.0033 ext. 390.

advertisement